CPD Events

Assessing; monitoring and supporting adherence in HTE patients: What to consider?

23 Nov 2022

About the event

This session will be the fifth in a series of short; virtual scientific webinars addressing specific questions about the treatment of heavily treatment experienced (HTE) patients with multidrug resistance (MDR). Despite a decline in prevalence and coverage over the years; MDR HIV is still an extremely relevant issue for HIV patients and clinicians alike. HTE patients with limited options remaining represent a critical area of unmet need; and must remain the subject of ongoing research; discussion and collaboration in the field of HIV. ViiV Healthcare invites you to join a series of engaging webinars led by global and regional experts in virology and the clinical management of MDR HIV patients. Each webinar will present a unique opportunity to explore a key question related to the HTE HIV population in Europe. There will be a focus on clinical case discussions to target understanding of treatment decisions and pathways for complex patients in clinical practice.

CPD Provider

ViiV Healthcare

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ViiV Healthcare

ViiV Healthcare

We are ViiV Healthcare: a global specialist HIV company, 100% focused on researching and delivering new medicines and improving access to care for people living with HIV. Our global headquarters are in Brentford, London UK; with our US headquarters in Research Triangle Park, North Carolina. 

Similar CPD Events

Healthcare & Medical

2024 and Beyond: From Congress to Clinical Practic...

ViiV Healthcare

This face-to-face; interactive and discussion-based meeting will be an opportunity to review scienti...
Lisbon,
21 Feb 2025
Healthcare & Medical

Best Practices and Challenges in Real-World Data:...

ViiV Healthcare

This in-person interactive course is ideal for the future generation of HIV specialists who wish to...
Vienna ,
20 Feb 2025